Cytoplasmic Expression of the EGFL6 Protein Is an Independent Prognostic Factor for Shortened Patient Survival in Human Hepatocellular Carcinoma
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Low expression of epidermal growth factor-like domain multiple 6 (EGFL6) in hepatocellular carcinoma (HCC) correlates with poor prognosis. Reduced EGFL6 is linked to advanced stage, recurrence, and worse survival, suggesting EGFL6 as a potential therapeutic target.
Area Of Science
- Oncology
- Molecular Biology
- Hepatology
Background
- Hepatocellular carcinoma (HCC) is a leading cause of cancer death globally.
- Understanding molecular markers is crucial for HCC diagnosis and treatment.
- Epidermal growth factor-like domain multiple 6 (EGFL6) role in HCC is largely unexplored.
Purpose Of The Study
- Investigate the clinical relevance of EGFL6 expression in HCC.
- Determine the diagnostic and prognostic significance of EGFL6 in HCC patients.
Main Methods
- Analyzed EGFL6 protein expression in 260 HCC tissue specimens using immunohistochemistry.
- Correlated EGFL6 expression with clinicopathological features and patient survival outcomes.
Main Results
- Found decreased cytoplasmic EGFL6 expression associated with poor differentiation, advanced T classification, vascular invasion, higher stage, and tumor recurrence.
- Reduced EGFL6 expression significantly correlated with worse disease-free survival (DFS) and disease-specific survival (DSS).
- EGFL6 identified as an independent predictor for decreased expression, differentiation grade, vascular invasion, stage, or recurrence.
Conclusions
- This is the first study to investigate EGFL6 protein expression in HCC.
- EGFL6 plays a significant role in HCC pathogenesis.
- Targeting EGFL6 may represent a promising therapeutic strategy for HCC.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...